Bayer UK Targets Mega-Brand Status For Berocca With Immuno Product Launch
Executive Summary
Bayer UK sees the recent launch of Berocca Immuno as a step towards "mega-brand" status for its line of effervescent VMS tablets.
You may also be interested in...
Top Five Takeaways From Bayer Consumer Health's 2022 Results
Beating global market growth, continuing macroeconomic headwinds and spin-off perspectives were among the key talking points as Bayer Consumer Health reported its 2022 sales and earnings.
Bayer Undresses UK Vaginal Health Stereotypes And Stigmas Via Canesten Schools Program
Bayer Consumer Health in a new campaign for UK women's intimate health brand Canesten hopes to “move imagery of real vulvas away from a sexualised depiction and into an informative, educational space to equip young people with the essential information they need to better understand their bodies as well as normalise conversations.”
'Alexa, Buy Berocca Boost' – Bayer Launches First 'Actionable' Consumer Health Ad In The UK
Bayer Consumer Health claims UK OTC industry first with "actionable ad" for its Berocca Boost dispersible vitamin and mineral supplement.